Sorting by

×

Moderna’s future clouded with vaccines facing new pressures

The obstacles prompted the company to reduce its sales expectations for the year. The shares fell more than 20 percent Thursday, erasing their 2024 gains.

Type of Content: 
Approved Story: 
1

Format: 
Hide on the following page types:: 
Front Page

Tag Pages

Topic Pages

Community Pages

News Item Format: 
Standard

Story Cluster: 
Autocurated: 
1

External ID: 
4315481

Share on: